Advancing mRNA-based cell therapies: the crucial role of mRNA optimization for therapeutic efficacy

Christian Bär, Ulrich Blache, Sandy Tretbar

23 January 2025

Viewpoint

Navigating the mRNA-LNP patent labyrinth: advice for developers

Dan Shores

07 November 2024

Viewpoint

History is the best teacher: what can RNA manufacturers learn from the challenges and successes of traditional biologics?

Adam Brown

01 November 2024

Viewpoint

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust

05 April 2024

Viewpoint

The evolving realm of nucleic acids: past, present, and future

Chris Mason

22 February 2024

Viewpoint

Opportunities and challenges in mRNA-LNP vaccine design

Rein Verbeke, Pieter R Cullis

17 April 2023

Viewpoint

Developing mRNA vaccines for malaria elimination

Nirbhay Kumar

11 April 2023

Viewpoint

What’s next for mRNA vaccines?

Jeffrey Ulmer

10 April 2023

Viewpoint

Exploring the potential of circular RNA

Piotr Kowalski

23 January 2023

Viewpoint

A bright future for lipid nanoparticles in gene therapy

Hongwei Zhang

09 July 2021

Viewpoint